FR2499413B1 - Procede de preparation d'une globuline anti-lymphocytes t - Google Patents

Procede de preparation d'une globuline anti-lymphocytes t

Info

Publication number
FR2499413B1
FR2499413B1 FR8123180A FR8123180A FR2499413B1 FR 2499413 B1 FR2499413 B1 FR 2499413B1 FR 8123180 A FR8123180 A FR 8123180A FR 8123180 A FR8123180 A FR 8123180A FR 2499413 B1 FR2499413 B1 FR 2499413B1
Authority
FR
France
Prior art keywords
preparation
lymphocyte globulin
globulin
lymphocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8123180A
Other languages
English (en)
Other versions
FR2499413A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Eduard Fresenius Chemisch Pharmazeutische Industrie KG
Original Assignee
Dr Eduard Fresenius Chemisch Pharmazeutische Industrie KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Eduard Fresenius Chemisch Pharmazeutische Industrie KG filed Critical Dr Eduard Fresenius Chemisch Pharmazeutische Industrie KG
Publication of FR2499413A1 publication Critical patent/FR2499413A1/fr
Application granted granted Critical
Publication of FR2499413B1 publication Critical patent/FR2499413B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR8123180A 1981-02-12 1981-12-11 Procede de preparation d'une globuline anti-lymphocytes t Expired FR2499413B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813105150 DE3105150A1 (de) 1981-02-12 1981-02-12 Herstellung von anti-t-lymphozyten-globulin.

Publications (2)

Publication Number Publication Date
FR2499413A1 FR2499413A1 (fr) 1982-08-13
FR2499413B1 true FR2499413B1 (fr) 1985-08-30

Family

ID=6124731

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8123180A Expired FR2499413B1 (fr) 1981-02-12 1981-12-11 Procede de preparation d'une globuline anti-lymphocytes t

Country Status (19)

Country Link
US (1) US4541953A (fr)
AT (1) AT377698B (fr)
AU (1) AU550257B2 (fr)
BE (1) BE891944A (fr)
CA (1) CA1184491A (fr)
CH (1) CH652410A5 (fr)
DE (1) DE3105150A1 (fr)
DK (1) DK56882A (fr)
ES (1) ES509504A0 (fr)
FI (1) FI72139C (fr)
FR (1) FR2499413B1 (fr)
GB (1) GB2093037B (fr)
HU (1) HU189998B (fr)
IT (1) IT1195296B (fr)
LU (1) LU83932A1 (fr)
NL (1) NL8200458A (fr)
NO (1) NO157422C (fr)
SE (1) SE460826B (fr)
ZA (1) ZA82905B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3483996D1 (de) * 1983-09-15 1991-02-28 Univ Leland Stanford Junior Allotransplantat mit verminderter immunogenitaet und verfahren und reagenz fuer seine herstellung.
US4681760A (en) * 1985-04-17 1987-07-21 The Board Of Trustees Of The Leland Stanford Junior University Method of conferring immunotolerance to a specific antigen
US5011684A (en) * 1985-09-05 1991-04-30 Beth Israel Hospital Association Lysing or blocking unwanted cells with IL-2 receptor-specific binding substance
US5785966A (en) * 1994-06-15 1998-07-28 Coles; John G. Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients
FR2878852B1 (fr) * 2000-09-28 2007-02-23 Imtix Sangstat Procede de production d'immunoglobulines anti-thymocytes humains

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363799A (en) * 1979-03-20 1982-12-14 Ortho Pharmaceutical Corporation Monoclonal antibody to human T cells, and methods for preparing same
US4361549A (en) * 1979-04-26 1982-11-30 Ortho Pharmaceutical Corporation Complement-fixing monoclonal antibody to human T cells, and methods of preparing same
US4361550A (en) * 1979-12-04 1982-11-30 Ortho Pharmaceutical Corporation Complement-fixing monoclonal antibody to human suppressor T cells and methods of preparing same
US4364935A (en) * 1979-12-04 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human prothymocyte antigen and methods of preparing same
US4364933A (en) * 1979-12-04 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human thymocyte antigen and methods of preparing same

Also Published As

Publication number Publication date
ES8401982A1 (es) 1984-01-16
AT377698B (de) 1985-04-25
IT1195296B (it) 1988-10-12
ES509504A0 (es) 1984-01-16
LU83932A1 (de) 1982-07-07
CA1184491A (fr) 1985-03-26
DE3105150C2 (fr) 1989-02-23
NO157422C (no) 1988-03-16
AU8037382A (en) 1982-08-19
GB2093037B (en) 1984-07-18
SE460826B (sv) 1989-11-27
DE3105150A1 (de) 1982-08-19
NO157422B (no) 1987-12-07
FI72139B (fi) 1986-12-31
IT8125247A0 (it) 1981-11-24
AU550257B2 (en) 1986-03-13
NO820014L (no) 1982-08-13
ATA11482A (de) 1984-09-15
CH652410A5 (de) 1985-11-15
GB2093037A (en) 1982-08-25
FI820233L (fi) 1982-08-13
DK56882A (da) 1982-08-13
NL8200458A (nl) 1982-09-01
FI72139C (fi) 1987-04-13
HU189998B (en) 1986-08-28
SE8200639L (sv) 1982-08-13
BE891944A (fr) 1982-05-17
US4541953A (en) 1985-09-17
ZA82905B (en) 1982-12-29
FR2499413A1 (fr) 1982-08-13

Similar Documents

Publication Publication Date Title
FR2549838B1 (fr) Procede de preparation d'alkylhalosilanes
PT75499A (fr) Procede pour la preparation de l'alkanoilanilides
FR2527615B1 (fr) Procede de preparation du 26,26,26,27,27,27-hexafluoro-1a,25-dihydroxycholesterol
FR2495134B1 (fr) Procede de preparation d'hydrocarbures
FR2550788B1 (fr) Nouveau procede de preparation d'a-6-desoxytetracyclines
PT75209A (fr) Procede de preparation d'amidobenzamides
BE892808A (fr) Procede pour la decomposition d'alkyl-tert-alkyl-ethers
FR2503158B1 (fr) Procede pour la preparation de dithiazolyldisulfures
PT73933B (fr) Procede de preparation de steroides 17 alpha-hidroxi 20-ceto 21-halogeno
FR2499413B1 (fr) Procede de preparation d'une globuline anti-lymphocytes t
FR2568126B3 (fr) Procede de preparation d'un elixir
PT74559A (fr) Procede de preparation de trifluoromethylphenyl-tetrahydropyri-dines substituees
FR2529202B1 (fr) Procede de preparation d'indoles
FR2560199B1 (fr) Procede de preparation de l'i-brassicasterol
FR2569194B3 (fr) Procede de preparation d'une aminolactone
MA19649A1 (fr) Procede de preparation d'haloalkyl-8-4h (1)-benzopyran-4-ones
PT75155B (fr) Procede de preparation d'ethylamines beta-cyclo-substituees
FR2541681B1 (fr) Procede de preparation d'acycloguanosine
PT75167B (fr) Procede pour la preparation de derives de cystine
BE892145A (fr) Procede de preparation de composes de omega-indol-3-yl-alkanol
FR2543141B1 (fr) Procede de preparation de l'azinomethyl-rifamycine
FR2554810B1 (fr) Procede de preparation d'aminobenzylamine
FR2517299B1 (fr) Procede de preparation du mononitrochlorobenzene
FR2505851B1 (fr) Procede de preparation d'emulsions bitumineuses
FR2500443B1 (fr) Procede de preparation d'acides dihalovinyl-cyclo-propane-carboxyliques